Plain-English translation of NCT06811324 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is testing how , a newer FDA-approved medication for weight loss, affects muscle mass, strength, and heart health in older adults who have obesity. While this medication is known to help people lose weight and control blood sugar, researchers want to understand exactly what kind of weight is lost—and whether losing weight this way might accidentally cause older adults to lose important muscle. This is a small pilot study with 20 participants in South Texas.
Older adults are at special risk when they lose weight, because they can lose muscle along with fat, which leads to weakness, falls, and disability. Researchers need to understand whether this medication causes muscle loss, so they can help older patients stay strong and healthy while losing weight.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will give yourself weekly injections of the medication under your skin at home. You will come to the research center for visits where researchers will measure your muscle strength, muscle mass, and heart health using tests and scans. The study will track how your body changes over time, and whether the weight you lose includes muscle or mostly fat.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States